The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Well-being, mood and calcium homeostasis in patients with hypoparathyroidism receiving standard treatment with calcium and vitamin D
Abstract
OBJECTIVE: Standard treatment in hypoparathyroidism consists of calcium and vitamin D (or vitamin D analogs) but does not employ replacement of the actual missing hormone. Only few studies have evaluated the efficacy of calcium/vitamin D treatment in hypoparathyroidism; the impact of chronic hypoparathyroid disease on well-being has not been investigated previously. DESIGN: Cross-sectional, controlled study in 25 unselected women with postsurgical hypoparathyroidism since 6.4plus minus8.0 years (s.d.) on stable treatment with calcium and vitamin D (or analogs) and in 25 controls with a history of thyroid surgery but intact parathyroid function, who were matched for sex, age and time since surgery. METHODS: Assessment of well-being and mood using validated questionnaires (the revised version Symptom Checklist 90 (SCL-90-R); the Giessen Complaint List (GBB-24); and the von Zerssen Symptom List (B-L Zerssen)), serum and urinary calcium/phosphorus homeostasis, and in the hypoparathyroid patients also screening for secondary disease by kidney ultrasound, ophthalmological split lamp examination, and measurement of bone mineral density. RESULTS: Serum calcium was in the accepted therapeutic range in the majority of hypoparathyroid patients. However, calcium/phosphorus homeostasis as a whole was clearly non-physiological. Nephrolithiasis was detected in 2 and cataracts in 11 of 25 hypoparathyroid patients. As compared with controls, hypoparathyroid patients had significantly higher global complaint scores in GBB-24 (P=0.036), B-L Zerssen (P=0.002) and SCL-90-R (P=0.020) with predominant increases in the subscale scores for anxiety, phobic anxiety and their physical equivalents. CONCLUSIONS: Current standard treatment in hypoparathyroidism is not only associated with an altered calcium/phosphorus homeostasis but also fails to restore well-being in these patients. Future studies need to address the impact of more physiological treatment options like parathyroid hormone(1-34) or parathyroid transplantation on well-being and mood in these patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SCL-90: an outpatient psychiatric rating scale--preliminary report.
Derogatis, L. R., Lipman, R. S., & Covi, L. (1973) · PubMed · Cited by 3,800
Dehydroepiandrosterone Replacement in Women with Adrenal Insufficiency
Arlt, W., Callies, F., van Vlijmen, J. C., Koehler, I., Reincke, M., Bidlingmaier, M., Huebler, D., Oettel, M., Ernst, M., Schulte, H. M., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909303411401 · Cited by 644
Self-citationThomusch, O., Machens, A., Sekulla, C., Ukkat, J., Lippert, H., Gastinger, I., & Dralle, H. (2000) · World Journal of Surgery · doi:10.1007/s002680010221 · Cited by 551
Differential effects of endocrine dysfunction on the axial and the appendicular skeleton.
Seeman, E., Wahner, H. W., Offord, K. P., Kumar, R., Johnson, W. J., & Riggs, B. L. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110570 · Cited by 463
Usdin, T. B., Gruber, C., & Bonner, T. I. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.26.15455 · Cited by 422
Fu, G. K., Lin, D., Zhang, M. Y. H., Bikle, D. D., Shackleton, C. H. L., Miller, W. L., & Portale, A. A. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.13.0035 · Cited by 398
TIP39: a new neuropeptide and PTH2-receptor agonist from hypothalamus
Usdin, T. B., Hoare, S. R. J., Wang, T., Mezey, É., & Kowalak, J. A. (1999) · Nature Neuroscience · doi:10.1038/14724 · Cited by 203
Pappalardo, G., Guadalaxara, A., Frattaroli, F. M., Illomei, G., & Falaschi, P. (2003) · European Journal of Surgery · doi:10.1080/110241598750005840 · Cited by 163
Duan, Y., Luca, V. D., & Seeman, E. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.2.5498 · Cited by 156
Parathyroid allotransplantation without immunosuppression
Hasse, C., Klöck, G., Schlosser, A., Zimmermann, U., & Rothmund, Μ. (1997) · The Lancet · doi:10.1016/s0140-6736(05)62473-7 · Cited by 150
Cited by
Bilezikian, J. P., Khan, A., Potts, J. T., Brandi, M. L., Clarke, B. L., Shoback, D., Jüppner, H., D'Amour, P., Fox, J., Rejnmark, L., et al. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.483 · Cited by 617
Shoback, D. (2008) · New England Journal of Medicine · doi:10.1056/nejmcp0803050 · Cited by 606
Bollerslev, J., Rejnmark, L., Marcocci, C., Shoback, D. M., Sitges-Serra, A., van Biesen, W., & Dekkers, O. M. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0628 · Cited by 462
Management of Hypoparathyroidism: Summary Statement and Guidelines
Brandi, M. L., Bilezikian, J. P., Shoback, D., Bouillon, R., Clarke, B. L., Thakker, R. V., Khan, A. A., & Potts, J. T. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3907 · Cited by 436
Long-Term Follow-Up of Patients with Hypoparathyroidism
Mitchell, D. M., Regan, S., Cooley, M. R., Lauter, K. B., Vrla, M. C., Becker, C. B., Burnett-Bowie, S.-A. M., & Mannstadt, M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1808 · Cited by 402
Metadata
- Authors
- Arlt, W., Fremerey, C., Callies, F., Reincke, M., Schneider, P., Timmermann, W., & Allolio, B.
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-02-01
- Volume
- 146
- Issue
- 2
- Pages
- 215-222
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2130815518
- Cited by
- 254
- References
- 26
- FWCI
- 1.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Well-being, mood and calcium homeostasis in patients with hypoparathyroidism receiving standard treatment with calcium and vitamin D. https://app.cochat.ai/papers/10.1530/eje.0.1460215
- The paper
- Arlt, W., Fremerey, C., Callies, F., Reincke, M., Schneider, P., Timmermann, W., & Allolio, B. (2002). Well-being, mood and calcium homeostasis in patients with hypoparathyroidism receiving standard treatment with calcium and vitamin D. European Journal of Endocrinology. https://doi.org/10.1530/eje.0.1460215
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.